HOME /

News

Below is a word cloud of of our abstract Book:

IHCON 2022 wordcloud

 

IHCON 2022 will be an in-person only meeting with ePoster gallery for viewing remotely! As of now (August 6), we have 207 regurlar registrations and 44 scholarship registrations for the meeting, 185 submitted abstracts, and Granlibakken is booked. A screen shot of the current registration by country and US states is shown below:

 

IHCON 2022 Registrations

Dear  IHCON Members,

Good news!  The New York Times reported that the virus testing mandate to enter/return to the U.S. by Air will be dropped. See details -> here.

 

Dear IHCON Members,

It is with great sadness that I have to inform you that the founder of IHCON, Dr. Sig Soli passed away on Monday April 11, 2022 of lung disease. I miss him very much. I remember fondly of our many worderful interactions at the Granlibakeen and during trips to South Korea. A link to his obituary can be found -> here.

-Sunil

------

Plans are now underway to have an in-person IHCON meeting.  

We have reserved the following 2022 dates at the Granlibakken:

  • IHAS pre meeting: Tuesday August 9 to Wednesday August 10th
  • IHCON meeting: Wednesday August 10th to Sunday August 14th

Please follow these steps: (1) Create your user  profile; (2) Submit your abstract; (3) Register for IHCON meetinig; and (4) Reserve hotel room.

Abstract submission site is now  open. Please visit ihcon.societyconference.com to (1) create your user profile, (2) start an  abstract  submission process, and (3) Register  for the meeting. To book a room at  the Granlibakken Conference center please visit -> Granlibakken Registration

We look forward to seeing you once again in 2022.

Sunil Puria, IHCON Chair

 

IHCON 2022 Technical Program Committee

Technical Chair: Louise Hickson, The University of Queensland, Australia

Co-Chairs: Tobias Neher, University of Southern Denmark and Karolina Smeds, ORCA Europe, Widex A/S, Sweden

Organizational Chair: Sunil Puria*, Harvard Medical School and Massachusetts Eye and Ear, USA

 

*Dr. Sunil Puria has a financial interest in Earlens Corporation, a company that develops and markets hearing aid products. Dr. Puria’s interests were reviewed and are managed by the Massachusetts Eye and Ear Infirmary and Partners HealthCare in accordance with their conflict of interest policies.